Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its stock performance relative to the benchmark index [7]. Core Insights - The company achieved a revenue of 2.947 billion yuan in 2024, representing a year-on-year growth of 7.20%. However, the net profit attributable to shareholders was -199 million yuan, a decline compared to the previous year [1]. - In Q1 2025, the company reported a revenue of 592 million yuan, down 6.20% year-on-year, but the net profit attributable to shareholders was 21.11 million yuan, an increase of 85.36% [1]. - The SaaS business showed significant growth, with the Annual Recurring Revenue (ARR) reaching 523.29 million yuan in 2024, a growth of approximately 25.1% from 418.29 million yuan in 2023 [3]. - The company has signed contracts with major hotel groups, enhancing its market position and expanding its international presence [4]. Financial Performance Summary - The gross profit margin for 2024 was 34.87%, a slight decrease from the previous year. In Q1 2025, the gross profit margin was 49.17%, remaining stable compared to the same period last year [2]. - Operating cash flow improved, with a net cash flow of 67.13 million yuan in 2024, up from 63.45 million yuan in the previous year. In Q1 2025, the operating cash flow was -110 million yuan, an improvement from -150 million yuan in Q1 2024 [2]. - The company expects revenues of 3.665 billion yuan in 2025, with a growth rate of 24.4%, and a projected net profit of 146 million yuan, marking a significant turnaround from the previous year's loss [8][9].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its stock performance relative to the benchmark index [7]. Core Insights - The company achieved a revenue of 2.947 billion yuan in 2024, representing a year-on-year growth of 7.20%. However, the net profit attributable to shareholders was -199 million yuan, showing a decline compared to the previous year [1]. - In Q1 2025, the company reported a revenue of 592 million yuan, down 6.20% year-on-year, but the net profit attributable to shareholders increased by 85.36% to 21.11 million yuan [1]. - The SaaS business showed significant growth, with the Annual Recurring Revenue (ARR) reaching 523.29 million yuan in 2024, a 25.1% increase from 418.29 million yuan in 2023 [3]. - The company has signed contracts with major hotel groups, enhancing its market position and expanding its international presence [4]. Financial Performance Summary - The gross profit margin for 2024 was 34.87%, a slight decrease from the previous year. In Q1 2025, the gross profit margin improved to 49.17% [2]. - Operating cash flow improved, with a net cash flow of 67.13 million yuan in 2024, compared to 63.45 million yuan in the previous year. However, Q1 2025 showed a negative cash flow of -110 million yuan [2]. - The company expects revenues of 3.665 billion yuan in 2025, with a growth rate of 24.4%, and a projected net profit of 146 million yuan [8][9]. Business Development - The company continues to expand its SaaS offerings, with over 80,000 hotel clients and a renewal rate exceeding 90% [3]. - The Daylight PMS system has been successfully implemented in 629 hotels globally, with significant contracts signed with major hotel groups [4]. - The company is also enhancing its retail business through the acquisition of minority stakes in software firms, which is expected to strengthen its market position in retail management solutions [6]. Future Projections - Revenue projections for 2025-2027 are 3.665 billion yuan, 4.576 billion yuan, and 5.720 billion yuan, respectively, with corresponding PS ratios of 6X, 5X, and 4X [7][8]. - The net profit is expected to recover significantly, reaching 579 million yuan by 2027, with a net profit margin improving over the years [9].

Financial Data and Key Metrics Changes - Total revenue for Q4 fiscal 2024 was $4.7 million, down from $5.4 million in Q4 fiscal 2023 [14] - For the twelve months ended January 31, 2025, revenue totaled $17.9 million, compared to $22.6 million in fiscal 2024 [14] - SaaS revenue for Q4 fiscal 2024 was $3.1 million, representing 66% of total revenue, down from $3.4 million or 64% in Q4 fiscal 2023 [15] - Net loss for Q4 fiscal 2024 was $2.1 million, compared to a net loss of $1.4 million in Q4 fiscal 2023 [16] - Cash and cash equivalents as of January 31, 2025, were $2.2 million, down from $3.2 million a year earlier [17] Business Line Data and Key Metrics Changes - Booked SaaS ACV as of January 31, 2025, was $14 million, increasing to $14.6 million by April 30, 2025 [7][14] - The company experienced $1.4 million in new SaaS ACV bookings, offset by $700,000 in churn due to client acquisitions [7] - SaaS revenue for the twelve months ending January 31, 2025, totaled $11.8 million, down from $14.1 million in the previous fiscal year [15] Market Data and Key Metrics Changes - The company noted a surge in denial activity across the industry, particularly from commercial payers, impacting revenue cycle management [11] - The introduction of denial prevention functionality is expected to significantly enhance the financial impact of the eValuator platform [10] Company Strategy and Development Direction - The company has decided to discontinue selling its quality module as an independent unit to focus resources on more impactful initiatives like denial prevention [9] - The new denial prevention functionality is expected to expand the inpatient financial impact of eValuator by over 15% and potentially double the impact on outpatient cases [10] - The company aims to achieve an EBITDA profitable run rate during the first half of fiscal 2025 [14][13] Management's Comments on Operating Environment and Future Outlook - Management emphasized the importance of helping healthcare systems succeed in revenue cycle management to ensure they are paid for the care provided [13] - The company is optimistic about future bookings due to increased client engagement and successful user stories shared at conferences [27] Other Important Information - The company amended certain financial covenants related to its senior term loan and revolving line of credit on March 28, 2025 [17] - An additional $1 million was drawn from the revolving line of credit after the fiscal period ended [18] Q&A Session Summary Question: Can you talk about the denials prevention product and its marketability? - Management highlighted the value of the new denial prevention functionality, which helps clients ensure claims are accurate before submission, addressing a significant industry issue [22][23] Question: What changes have enabled quicker implementation timelines? - Management noted improvements in standardizing data and training, resulting in reduced implementation times for eValuator from four to six months to two to three months [25][26] Question: What gives confidence in building momentum for stronger bookings? - Management indicated that increased client engagement and successful case studies shared at events have led to more top-of-funnel activity, suggesting a positive trend in bookings [27][28]